D. Hirtz, How common are the "common" neurologic disorders? Neurol, vol.68, pp.326-337, 2007.

A. M. Graybiel, The basal ganglia, Curr. Biol, vol.10, pp.509-511, 2000.

W. Dauer and S. Przedborski, Parkinson's disease: mechanisms and models, Neuron, vol.39, pp.889-909, 2003.

R. A. Hauser, Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa, Mov. Disord, vol.22, pp.2409-2417, 2007.

C. R. Gerfen, D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons, Sci, vol.250, pp.1429-1432, 1990.

D. L. Rosin, B. D. Hettinger, A. Lee, and J. Linden, Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function, Neurol, vol.61, pp.12-18, 2003.

P. Calabresi, Muscarinic IPSPs in rat striatal cholinergic interneurones, J. Physiol, vol.510, issue.2, pp.421-427, 1998.

S. Grady, M. J. Marks, S. Wonnacott, and A. C. Collins, Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum, J. Neurochem, vol.59, pp.848-856, 1992.

E. Galarraga, Cholinergic modulation of neostriatal output: a functional antagonism between different types of muscarinic receptors, J. Neurosci, vol.19, pp.3629-3638, 1999.

D. K. Grandy, Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes, Proc. Natl Acad. Sci. USA, vol.88, pp.9175-9179, 1991.

Z. U. Khan, Dopamine D5 receptors of rat and human brain, Neurosci, vol.100, pp.689-699, 2000.

M. Tiberi, Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor, Proc. Natl Acad. Sci. USA, vol.88, pp.7491-7495, 1991.

S. M. Nicola, J. Surmeier, and R. C. Malenka, Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens, Annu. Rev. Neurosci, vol.23, pp.185-215, 2000.

Z. Yan and D. J. Surmeier, D5 dopamine receptors enhance Zn2+-sensitive GABA(A) currents in striatal cholinergic interneurons through a PKA/PP1 cascade, Neuron, vol.19, pp.1115-1126, 1997.

A. Rivera, Molecular phenotype of rat striatal neurons expressing the dopamine D5 receptor subtype, Eur. J. Neurosci, vol.16, pp.2049-2058, 2002.

T. R. Hollon, Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive, J. Neurosci, vol.22, pp.10801-10810, 2002.

A. Holmes, Behavioral characterization of dopamine D5 receptor null mutant mice, Behav. Neurosci, vol.115, pp.1129-1144, 2001.

E. E. Elliot, D. R. Sibley, and J. L. Katz, Locomotor and discriminative-stimulus effects of cocaine in dopamine D5 receptor knockout mice, Psychopharmacol, vol.169, pp.161-168, 2003.

R. M. Karlsson, K. R. Hefner, D. R. Sibley, and A. Holmes, Comparison of dopamine D1 and D5 receptor knockout mice for cocaine locomotor sensitization, Psychopharmacol, vol.200, pp.117-127, 2008.

S. Hayashizaki, Methamphetamine increases locomotion and dopamine transporter activity in dopamine d5 receptor-deficient mice, PLoS One, vol.8, 2013.

J. Sarinana and S. Tonegawa, Differentiation of forebrain and hippocampal dopamine 1-class receptors, D1R and D5R, in spatial learning and memory, Hippocampus, vol.26, pp.76-86, 2016.

G. V. Carr, F. Maltese, D. R. Sibley, D. R. Weinberger, and F. Papaleo, The Dopamine D5 Receptor Is Involved in Working Memory, Front. Pharmacol, vol.8, 2017.

M. L. Perreault, J. Jones-tabah, B. F. O'dowd, and S. R. George, A physiological role for the dopamine D5 receptor as a regulator of BDNF and Akt signalling in rodent prefrontal cortex, Int. J. Neuropsychopharmacol, vol.16, pp.477-483, 2013.

C. R. Gerfen, S. Miyachi, R. Paletzki, and P. Brown, D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase, J. Neurosci, vol.22, pp.5042-5054, 2002.

N. Pavon, A. B. Martin, A. Mendialdua, and R. Moratalla, ERK phosphorylation and FosB expression are associated with L-DOPAinduced dyskinesia in hemiparkinsonian mice, Biol. Psychiatry, vol.59, pp.64-74, 2006.

J. E. Westin, L. Vercammen, E. M. Strome, C. Konradi, and M. A. Cenci, Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors, Biol. Psychiatry, vol.62, pp.800-810, 2007.

M. Cerovic, Derangement of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and extracellular signal-regulated kinase (ERK) dependent striatal plasticity in L-DOPA-induced dyskinesia, Biol. Psychiatry, vol.77, p.2, 2015.

E. Santini, Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPAinduced dyskinesia, J. Neurosci, vol.27, pp.6995-7005, 2007.

S. Fasano, Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia, Proc. Natl Acad. Sci. U S Am, vol.107, pp.21824-21829, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01055134

S. A. Lim, Enhanced histamine H2 excitation of striatal cholinergic interneurons in L-DOPA-induced dyskinesia, Neurobiol. Dis, vol.76, pp.67-76, 2015.

W. Shen, M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia, Neuron, vol.88, pp.762-773, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01331717

Y. Ding, Enhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian mice, Proc. Natl Acad. Sci. USA, vol.108, pp.840-845, 2011.

M. F. Bastide, Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease, Prog. Neurobiol, vol.132, pp.96-168, 2015.

O. Solis, J. R. Garcia-montes, A. Gonzalez-granillo, M. Xu, and R. Moratalla, Dopamine D3 Receptor Modulates l-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling, Cereb. Cortex, 2015.

V. Francardo, Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease, Neurobiol. Dis, vol.42, pp.327-340, 2011.

G. Flores, Expression of dopamine receptors in the subthalamic nucleus of the rat: characterization using reverse transcriptasepolymerase chain reaction and autoradiography, Neurosci, vol.91, pp.633-635, 1999.

J. Bertran-gonzalez, B. C. Chieng, V. Laurent, E. Valjent, and B. W. Balleine, Striatal cholinergic interneurons display activity-related phosphorylation of ribosomal protein S6, PLoS One, vol.7, 2012.

T. Bordia, C. Campos, L. Huang, and M. Quik, Continuous and intermittent nicotine treatment reduces L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesias in a rat model of Parkinson's disease, J. Pharmacol. Exp. Ther, vol.327, pp.239-247, 2008.

G. J. O'sullivan, Dopamine D1 vs D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1/2 and GluR1-AMPA signalling, Neuropharmacol, vol.54, pp.1051-1061, 2008.

A. D. Abraham, K. A. Neve, and K. M. Lattal, Activation of D1/5 Dopamine Receptors: A Common Mechanism for Enhancing Extinction of Fear and Reward-Seeking Behaviors, Neuropsychopharmacology, vol.41, pp.2072-2081, 2016.

Z. G. Leng, Activation of DRD5 (dopamine receptor D5) inhibits tumor growth by autophagic cell death, Autophagy, vol.13, pp.1404-1419, 2017.

A. Sahu, K. R. Tyeryar, H. O. Vongtau, D. R. Sibley, and A. S. Undieh, D5 dopamine receptors are required for dopaminergic activation of phospholipase C, Mol. Pharmacol, vol.75, pp.447-453, 2009.

J. L. Conroy, R. B. Free, and D. R. Sibley, Identification of G protein-biased agonists that fail to recruit beta-arrestin or promote internalization of the D1 dopamine receptor, ACS Chem. Neurosci, vol.6, pp.681-692, 2015.

C. Guigoni, 1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates, Neurobiol. Dis, vol.26, pp.452-463, 2007.

C. Rangel-barajas, L-DOPA-induced dyskinesia in hemiparkinsonian rats is associated with up-regulation of adenylyl cyclase type V/VI and increased GABA release in the substantia nigra reticulata, Neurobiol. Dis, vol.41, pp.51-61, 2011.

D. Herve, G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase, J. neuroscience: Off. J. Soc. Neurosci, vol.13, pp.2237-2248, 1993.

G. J. O'sullivan, Ethological resolution of behavioural topography and D1-like versus D2-like agonist responses in congenic D5 dopamine receptor mutants: identification of D5:D2-like interactions, Synap, vol.55, pp.201-211, 2005.

H. Zhang, L. Ma, F. Wang, J. Chen, and X. Zhen, Chronic SKF83959 induced less severe dyskinesia and attenuated L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease, Neuropharmacol, vol.53, pp.125-133, 2007.

C. Alcacer, Galpha(olf) mutation allows parsing the role of cAMP-dependent and extracellular signal-regulated kinasedependent signaling in L-3,4-dihydroxyphenylalanine-induced dyskinesia, J. Neurosci, vol.32, pp.5900-5910, 2012.

M. Cortes, CK2 oppositely modulates L-DOPA induced dyskinesia via striatal projection neurons expressing D1-or D2-receptors, J Neurosci, 2017.

Z. Yan, W. J. Song, and J. Surmeier, D2 dopamine receptors reduce N-type Ca2+ currents in rat neostriatal cholinergic interneurons through a membrane-delimited, protein-kinase-C-insensitive pathway, J. Neurophysiol, vol.77, pp.1003-1015, 1997.

X. A. Perez, T. Bordia, and M. Quik, The striatal cholinergic system in L-dopa-induced dyskinesias, J. Neural Transm, vol.125, pp.1251-1262, 2018.

T. Perez-rosello, Cholinergic control of firing pattern and neurotransmission in rat neostriatal projection neurons: role of CaV2.1 and CaV2.2 Ca2+ channels, J. Neurophysiol, vol.93, pp.2507-2519, 2005.

Z. Yan, J. Flores-hernandez, and D. J. Surmeier, Coordinated expression of muscarinic receptor messenger RNAs in striatal medium spiny neurons, Neurosci, vol.103, pp.1017-1024, 2001.

J. A. Goldberg, J. B. Ding, and D. J. Surmeier, Muscarinic modulation of striatal function and circuitry, Handb Exp Pharmacol, pp.223-241, 2012.

L. Won, Y. Ding, P. Singh, and U. J. Kang, Striatal cholinergic cell ablation attenuates L-DOPA induced dyskinesia in Parkinsonian mice, J. neuroscience: Off. J. Soc. Neurosci, vol.34, pp.3090-3094, 2014.

T. Bordia, X. A. Perez, J. Heiss, D. Zhang, and M. Quik, Optogenetic activation of striatal cholinergic interneurons regulates L-dopainduced dyskinesias, Neurobiol. Dis, vol.91, pp.47-58, 2016.

P. Aldrin-kirk, Chemogenetic modulation of cholinergic interneurons reveals their regulating role on the direct and indirect output pathways from the striatum, Neurobiol. Dis, vol.109, pp.148-162, 2018.

S. M. Hersch, C. A. Gutekunst, H. D. Rees, C. J. Heilman, and A. I. Levey, Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype-specific antibodies, J. Neurosci, vol.14, pp.3351-3363, 1994.

F. Laplante, C. W. Stevenson, A. Gratton, L. K. Srivastava, and R. Quirion, Effects of neonatal ventral hippocampal lesion in rats on stressinduced acetylcholine release in the prefrontal cortex, J. Neurochem, vol.91, pp.1473-1482, 2004.

D. Centonze, Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity, J. Neurosci, vol.23, pp.8506-8512, 2003.

K. J. Livak and T. D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, vol.25, pp.402-408, 2001.

M. Lundblad, Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease, Eur. J. Neurosci, vol.15, pp.120-132, 2002.

M. Lundblad, Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia, Exp. Neurol, vol.194, pp.66-75, 2005.